NGM
VOYA Investment Management’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-19,603
| Closed | -$50.8K | – | 2938 |
|
|
2023
Q2 | $50.8K | Buy |
19,603
+4,027
| +26% | +$10.4K | ﹤0.01% | 2899 |
|
|
2023
Q1 | $63.6K | Hold |
15,576
| – | – | ﹤0.01% | 2768 |
|
|
2022
Q4 | $78.2K | Hold |
15,576
| – | – | ﹤0.01% | 2798 |
|
|
2022
Q3 | $204K | Buy |
15,576
+1,078
| +7% | +$14.1K | ﹤0.01% | 2597 |
|
|
2022
Q2 | $186K | Buy |
14,498
+2,032
| +16% | +$26.1K | ﹤0.01% | 2425 |
|
|
2022
Q1 | $190K | Hold |
12,466
| – | – | ﹤0.01% | 2384 |
|
|
2021
Q4 | $221K | Buy |
12,466
+207
| +2% | +$3.67K | ﹤0.01% | 2455 |
|
|
2021
Q3 | $258K | Hold |
12,259
| – | – | ﹤0.01% | 2424 |
|
|
2021
Q2 | $242K | Buy |
12,259
+1,334
| +12% | +$26.3K | ﹤0.01% | 2491 |
|
|
2021
Q1 | $318K | Buy |
10,925
+467
| +4% | +$13.6K | ﹤0.01% | 2290 |
|
|
2020
Q4 | $317K | Buy |
+10,458
| New | +$317K | ﹤0.01% | 2167 |
|
|
2020
Q2 | – | Sell |
-12,524
| Closed | -$154K | – | 2649 |
|
|
2020
Q1 | $154K | Buy |
12,524
+882
| +8% | +$10.8K | ﹤0.01% | 2220 |
|
|
2019
Q4 | $215K | Buy |
+11,642
| New | +$215K | ﹤0.01% | 2349 |
|